Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

FDA 510(k)

Adaptive Biotechnologies clonoSEQ Assay

N.º K: K200009 · 2020-08-05

SolicitanteAdaptive Biotechnologies Corporation
Fecha de decisión2020-08-05
Código de productoQDC
Comité asesorPA
DecisiónSubstantially Equivalent

Resumen del dispositivo

Adaptive Biotechnologies clonoSEQ Assay is the device name listed in this FDA 510(k) record. The listed applicant is Adaptive Biotechnologies Corporation. It received FDA 510(k) clearance on 2020-08-05 under 510(k) number K200009. The device is classified under product code QDC. It was reviewed by the PA advisory panel. FDA Decision: Substantially Equivalent.

Preguntas frecuentes

What is the Adaptive Biotechnologies clonoSEQ Assay?

Adaptive Biotechnologies clonoSEQ Assay is a medical device that received FDA 510(k) clearance on 2020-08-05. The listed applicant is Adaptive Biotechnologies Corporation. The 510(k) number is K200009.

When did Adaptive Biotechnologies clonoSEQ Assay receive FDA 510(k) clearance?

Adaptive Biotechnologies clonoSEQ Assay received FDA 510(k) clearance on 2020-08-05, under 510(k) number K200009.

Who is the listed applicant for Adaptive Biotechnologies clonoSEQ Assay?

The FDA 510(k) record lists Adaptive Biotechnologies Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Adaptive Biotechnologies clonoSEQ Assay?

The FDA product code for Adaptive Biotechnologies clonoSEQ Assay is QDC.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑